R. Pearcey
About
R. Pearcey is a scholar working on Obstetrics and Gynecology, Pulmonary and Respiratory Medicine and Radiation.
According to data from OpenAlex, R. Pearcey has authored 73 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Obstetrics and Gynecology, 23 papers in Pulmonary and Respiratory Medicine and 20 papers in Radiation. Recurrent topics in R. Pearcey's work include Endometrial and Cervical Cancer Treatments (25 papers), Advanced Radiotherapy Techniques (20 papers) and Ovarian cancer diagnosis and treatment (13 papers). R. Pearcey is often cited by papers focused on Endometrial and Cervical Cancer Treatments (25 papers), Advanced Radiotherapy Techniques (20 papers) and Ovarian cancer diagnosis and treatment (13 papers). R. Pearcey collaborates with scholars based in Canada, United States and India. R. Pearcey's co-authors include William J. Mackillop, Daniel G. Petereit, Will D. King, Marc Kerba, G. Dundas, Chen Zheng, Valerie Capstick, Gavin Stuart, Kerry S. Courneya and Katia Tonkin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
R. Pearcey
71 papers receiving 2.9k citations
Peers
R. Pearcey
Jean B. Owen United States
Ida Ackerman Canada
Junzo Chino United States
Joseph L. Kelley United States
Annerie Slot Netherlands
Himu Lukka Canada
M. Resbeut France
Emmanuel Barranger France
Francesca De Felice Italy
Jennifer Moughan United States
Citations per year, relative to R. Pearcey R. Pearcey (= 1×)
peers
Jean B. Owen
Countries citing papers authored by R. Pearcey
Since
Specialization
Citations
This map shows the geographic impact of R. Pearcey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Pearcey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Pearcey more than expected).
Fields of papers citing papers by R. Pearcey
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by R. Pearcey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Pearcey. The network helps show where R. Pearcey may publish in the future.
Co-authorship network of co-authors of R. Pearcey
This figure shows the co-authorship network connecting the top 25 collaborators of R. Pearcey. A scholar is included among the top collaborators of R. Pearcey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Pearcey. R. Pearcey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wang, Michael H., Larissa J. Vos, Don Yee, et al.. (2021). Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer. Practical Radiation Oncology. 11(5). 384–393.
2.
Croke, Jennifer, Anthony Fyles, Lisa Barbera, et al.. (2016). Radiation therapy quality-of-care indicators for locally advanced cervical cancer: A consensus guideline. Practical Radiation Oncology. 6(5). 315–323.
3.
Menon, Geetha, Fleur Huang, Ron S. Sloboda, R. Pearcey, & Sunita Ghosh. (2014). Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: A planning study. Brachytherapy. 13(6). 572–578.
4.
Amanie, John, Melinda Wuest, Nadeem Pervez, et al.. (2013). Analysis of Intraprostatic Therapeutic Effects in Prostate Cancer Patients Using [11C]-Choline pet/ct after External-Beam Radiation Therapy. Current Oncology. 20(2). 104–110.
5.
Brundage, Michael, Brita Danielson, R. Pearcey, et al.. (2013). A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer. Radiotherapy and Oncology. 107(3). 339–345.
6.
Hay, Annette E., Beate Klimm, Bingshu E. Chen, et al.. (2013). An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. Annals of Oncology. 24(12). 3065–3069.
7.
Kupets, Rachel, Tien Le, J. Bentley, et al.. (2013). RETIRED: The Role of Adjuvant Therapy in Endometrial Cancer. Journal of Obstetrics and Gynaecology Canada. 35(4). 375–376.
8.
Pervez, Nadeem, Cormac Small, M. Mackenzie, et al.. (2009). Acute Toxicity in High-Risk Prostate Cancer Patients Treated With Androgen Suppression and Hypofractionated Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 76(1). 57–64.
9.
Pearcey, R., et al.. (2009). The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: A 20-year institutional review. Brachytherapy. 8(3). 278–283.
10.
Mackenzie, M., Kurian Joseph, Nadeem Pervez, et al.. (2008). Assessment of Extended-Field Radiotherapy for Stage IIIC Endometrial Cancer Using Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, and Helical Tomotherapy. International Journal of Radiation Oncology*Biology*Physics. 70(3). 935–943.
11.
Dundas, G., et al.. (2008). Twenty-year review of radiotherapy for vaginal cancer: An institutional experience. Gynecologic Oncology. 111(2). 298–306.
12.
Zheng, Chen, Will D. King, R. Pearcey, Marc Kerba, & William J. Mackillop. (2007). The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature. Radiotherapy and Oncology. 87(1). 3–16.
13.
Karvinen, Kristina H., Kerry S. Courneya, Kristin L. Campbell, et al.. (2007). Correlates of exercise motivation and behavior in a population-based sample of endometrial cancer survivors: an application of the Theory of Planned Behavior. International Journal of Behavioral Nutrition and Physical Activity. 4(1). 21–21.
14.
Meyer, Ralph M., Mary Gospodarowicz, Joseph M. Connors, et al.. (2005). Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. 23(21). 4634–4642.
15.
Pearcey, R. & Daniel G. Petereit. (2000). Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiotherapy and Oncology. 56(1). 17–22.
16.
Britten, Richard A., Andrew Evans, M. Joan Allalunis‐Turner, & R. Pearcey. (1996). Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. International Journal of Radiation Oncology*Biology*Physics. 34(2). 367–374.
17.
Pearcey, R., Gavin Stuart, Grant D. MacLean, et al.. (1995). Phase II Study to Evaluate the Toxicity and Efficacy of Concurrent Cisplatin and Radiation Therapy in the Treatment of Patients with Locally Advanced Squamous Cell Carcinoma of the Cervix. Gynecologic Oncology. 58(1). 38–41.
18.
Pearcey, R. & Grant D. MacLean. (1992). A phase I/II study combining radical radiotherapy with concurrent cisplatin in the treatment of advanced squamous cell carcinoma of the cervix. International Journal of Gynecological Cancer. 2(4). 215–219.
19.
Pearcey, R., Robert Calvert, & A. C. Mehta. (1988). Disposition of ifosfamide in patients receiving ifosfamide infusion therapy for the treatment of cervical carcinoma. Cancer Chemotherapy and Pharmacology. 22(4). 353–5.
20.
Pearcey, R., et al.. (1987). Quality control in radiotherapy: The reduction of field placement errors. International Journal of Radiation Oncology*Biology*Physics. 13(10). 1583–1588.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jean B. Owen Breakdown of academic impact, for papers by Ida Ackerman Breakdown of academic impact, for papers by Junzo Chino Breakdown of academic impact, for papers by Joseph L. Kelley Breakdown of academic impact, for papers by Annerie Slot Breakdown of academic impact, for papers by Himu Lukka Breakdown of academic impact, for papers by M. Resbeut Breakdown of academic impact, for papers by Emmanuel Barranger Breakdown of academic impact, for papers by Francesca De Felice Breakdown of academic impact, for papers by Jennifer Moughan